MedPath

INSTITUT CLAUDIUS REGAUD

🇫🇷France
Ownership
Private
Employees
-
Market Cap
-
Website
http://www.claudiusregaud.fr

Circulating " Cancer Cells / Macrophage " HYbrid Cells in Patients With Sarcoma, Part 2

Not Applicable
Recruiting
Conditions
Leiomyosarcoma
Interventions
Other: Blood samples will be collected at different times.
First Posted Date
2022-06-22
Last Posted Date
2024-12-13
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
20
Registration Number
NCT05427461
Locations
🇫🇷

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France

Study Evaluating DNA Double-strand Breaks (DSBs) REpair Factors (POLQ, Shieldin Complex and 53BP1) Expression as Biomarker of PARP Inhibitor Resistance in Patients With Deleterious Germline Mutation in BRCA 1/2 and HER2-negative, Metastatic or Locally Advanced Breast Cancer.

Not Applicable
Recruiting
Conditions
Breast Cancer
First Posted Date
2022-05-18
Last Posted Date
2024-06-21
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
120
Registration Number
NCT05378204
Locations
🇫🇷

Chru de Tours, Tours, France

🇫🇷

Centre Hospitalier Départemental Vendée, La Roche-sur-Yon, France

🇫🇷

Centre Leon Berard, Lyon, France

and more 22 locations

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

Recruiting
Conditions
Pediatric Solid Tumor
Ependymoma of Brain
First Posted Date
2021-12-09
Last Posted Date
2022-12-23
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
370
Registration Number
NCT05151718
Locations
🇫🇷

Institut Claudius Regaud, Toulouse, France

Evaluation of the Interest of a Video-assisted Remote Speech Therapy Consultation in Patients With ORL Cancer (TELE ORTHOPHONIE)

Not Applicable
Recruiting
Conditions
ORL Cancer
Interventions
Other: Patient managed at the IUCT-O and by a private speech therapist (near the patient's home).
First Posted Date
2021-06-25
Last Posted Date
2024-06-10
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
105
Registration Number
NCT04940000
Locations
🇫🇷

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France

Cholesterol Metabolites Analysis in Human Thyroid and Iodine Resistance

Completed
Conditions
Thyroid Cancer
Interventions
Other: Metabolites dosage
First Posted Date
2021-03-29
Last Posted Date
2023-05-01
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
30
Registration Number
NCT04821336
Locations
🇫🇷

Institut Claudius regaud IUCT Oncopole, Toulouse, France

Circulating Cancer Cells/Macrophage HYbrid Cells in Patients With Breast Cancer.

Not Applicable
Completed
Conditions
Breast Cancer
Interventions
Other: Patients with breast cancer (stage I, II III or IV)
First Posted Date
2021-03-26
Last Posted Date
2022-09-28
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
61
Registration Number
NCT04818125
Locations
🇫🇷

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France

Study to Evaluate the Impact of the Use of Alternative and Complementary Therapies on Therapeutic Adherence in Patients Treated With taMoxifen for Early Stage Breast Cancer

Not Applicable
Recruiting
Conditions
Breast Cancer
Interventions
Other: Treatment requiring adjuvant Hormonal Therapy (HT) with tamoxifen.
First Posted Date
2021-02-05
Last Posted Date
2024-04-09
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
200
Registration Number
NCT04740697
Locations
🇫🇷

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France

Study to Evaluate the Interest of Qutenza in Patients With Head and Neck Cancer in Remission and With Sequelae Neuropathic Pain.

Phase 2
Recruiting
Conditions
Head and Neck Cancer
Interventions
Drug: Capsaïcin patch (Qutenza®)
Drug: Amitriptyline (Laroxyl®)
First Posted Date
2021-01-11
Last Posted Date
2024-07-10
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
130
Registration Number
NCT04704453
Locations
🇫🇷

Hôpital Saint-Joseph, Marseille, France

🇫🇷

INSTITUT DE CANCEROLOGIE DE L'OUEST (ICO) Site Angers, Angers, France

🇫🇷

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France

and more 1 locations

Single-Cell Map of Immune and Lymphoma Cells in B-cell Non-Hodgkin's Lymphoma

Not Applicable
Active, not recruiting
Conditions
Diffuse Large B-cell Lymphoma
Interventions
Other: Patient with histologically confirmed diffuse large B-cell lymphoma with a planned first line treatment by R-CHOP.
First Posted Date
2021-01-06
Last Posted Date
2023-11-08
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
60
Registration Number
NCT04696692
Locations
🇫🇷

Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France

Efficacy of Pre-operative Prehabilitation in Patients With Limb Sarcoma

Phase 2
Recruiting
Conditions
Sarcoma
Interventions
Other: Surgical prehabilitation program.
First Posted Date
2020-08-17
Last Posted Date
2024-08-29
Lead Sponsor
Institut Claudius Regaud
Target Recruit Count
53
Registration Number
NCT04515459
Locations
🇫🇷

Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France

© Copyright 2025. All Rights Reserved by MedPath